Form D · Biotechnology
PTC THERAPEUTICS, INC.
South Plainfield, NJ · CIK 0001070081
Offering snapshot reported May 8, 2023 · SEC filing
- Reported sold
- $35.9M Offering amount: $35.9M
- Investors reported
- 40 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 10, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 8, 2023 | Initial | $35,897,425 | No comparison | 40 | SEC filing |
| Jun 12, 2020 | Initial | $41,905,000 | No comparison | 38 | SEC filing |
| May 14, 2020 | Initial | $140,949,151 | No comparison | 57 | SEC filing |
| Sep 5, 2018 | Initial | $150,000,000 | No comparison | 52 | SEC filing |
| May 15, 2013 | Initial | $4,500,000 | No comparison | 1 | SEC filing |
| Mar 21, 2013 | Initial | $59,999,448 | No comparison | 32 | SEC filing |
| Feb 12, 2013 | Initial | $2,000,100 | No comparison | 25 | SEC filing |
| Jun 13, 2012 | Initial | $22,950,840 | No comparison | 27 | SEC filing |
| Dec 22, 2009 | Initial | $25,150,064 | No comparison | 21 | SEC filing |
| Oct 7, 2009 | Initial | $0 | No comparison | 2 | SEC filing |
| Sep 28, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 29, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 12, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-481052
Common Stock
Source: Form D, filed May 8, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard Aldrich | Director |
| Neil Almstead | Executive |
| Neil Almstead, Ph.D | Executive |
| William Baird, Iii | Executive |
| Axel Bolte | Director |
| Mark E. Boulding | Executive |
| Soren Carlsen | Director |
| Carl Goldfischer | Director |
| Emily Hill | Executive |
| Claudia Hirawat | Executive |
| Allan S. Jacobson | Director |
| Allan Jacobson, Ph.D. | Director |
| Matthew Klein | Executive |
| Matthew B. Klein, M.D. | Director, Executive |
| Adam Koppel | Director |
| Michael Kranda | Director |
| Geoffrey Mc Donough | Director |
| Langdon L. Miller | Executive |
| Langon L. Miller | Executive |
| Stephanie S. Okey | Director |
| Stepanie S. Okey | Director |
| Deepa Pakianathan | Director |
| Eric Pauwels | Executive |
| Stuart W. Peltz | Director, Executive |
| Emma Reeve | Director |
| Michael Schmertzler | Director |
| Mary Smith | Director |
| David P. Southwell | Director |
| Marcio Souza | Executive |
| Glenn D. Steele, Jr. | Director |
| Glenn D. Steele Jr., M.D., Ph.D. | Director |
| Peter Svennilson | Director |
| Dawn Svoronos | Director |
| Christine Utter | Executive |
| Alethia Young | Director |
| Jerome B. Zeldis | Director |
| Jerome B. Zeldis, M.D., Ph.D. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 Corporate Court
South Plainfield, NJ, 07080-2449
South Plainfield, NJ, 07080-2449